Jazz Pharmaceuticals JAZZ Additions for tax positions of prior years
Additions for tax positions of prior years at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's additions for tax positions of prior years.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's additions for tax positions of prior years?
- Jazz Pharmaceuticals (JAZZ) reported additions for tax positions of prior years of $299.75K in Q4 2025.
- What is the long-term trend for Jazz Pharmaceuticals's additions for tax positions of prior years?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's additions for tax positions of prior years has grown at a 54.4% compound annual growth rate (CAGR), from $211K to $1.2M.
- What does additions for tax positions of prior years mean?
- The increase in tax uncertainty related to tax positions taken in previous years.
- How do you interpret additions for tax positions of prior years?
- Frequent or large increases may indicate historical tax positions that are increasingly being challenged or re-evaluated by the company or tax authorities.
- How does additions for tax positions of prior years compare across companies?
- Commonly reported by large-cap firms; high levels relative to total tax reserves may indicate potential future tax audit exposure.